Andy Christensen, PharmD, BCOP

Andy Christensen, PharmD, BCOP

  • Clinical Pharmacy Specialist
  • Assistant Professor, The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science

Board Certification

  • BCOP


  • BS – Christian Brothers University, Memphis, Tennessee
  • PharmD - University of Tennessee College of Pharmacy, Memphis, Tennessee

Post-Graduate Training

  • PGY1 Pharmacy Practice Residency – Children’s Hospital of The King’s Daughters, Norfolk, Virginia
  • PGY2 Oncology Practice Residency – St. Jude Children’s Research Hospital, Memphis, Tennessee

Focused Area of Practice

  • Solid Tumor/Neuro-oncology


  • 2010 Pediatric Pharmacy Advocacy Group Best Practice Award

Research Interest

  • Pharmacokinetics and pharmacodynamics of pediatric cancer therapies

St. Jude Committee Service

  • Pharmaceutical Department Residency Committee
  • Metabolic Infusion Support Services Subcommittee

Pharmacy Organizations/Committee Service

  • Children’s Oncology Group
  • American Pharmacists Association
  • American Society of Health-System Pharmacists
  • American College of Clinical Pharmacy
  • Pediatric Pharmacy Advocacy Group
  • Hematology Oncology Pharmacy Association

Selected Publications

Chow JW, Chicella MF, Christensen AM, Moneymaker CS, Harrington J, Dice JE. Improving Palivizumab Compliance rough a Pharmacist-Managed RSV Prevention Clinic. J Pediatr Pharmacol Ther. 2017 Sep-Oct;22(5):338-343. 

Vivek Subbiah, Jitesh D Kawedia, Anthony Christensen, Kenneth R. Hess, Kayuri Patel, Elaine Wood, Ryan D Bitar, Najat C. Daw. Comparison of adult oncology phase 1 trials to pediatric oncology phase 1 trials of targeted therapies. J Clin Oncol 33, 2015 (suppl; abstr 2581)

Michael P Stanton, PharmD;  Anthony M Christensen, PharmD;  Maria Estela Ceja, PharmD;  Suzanne C Gettys, PharmD;  Alison M Gulbis, PharmD; Priti Tewari, MD. Pre-transplant Serum Ferritin Level and Development of Liver Complications in a Pediatric, Adolescent and Young Adult Allogeneic Hematopoietic Stem Cell Transplant Population. HOPA Annual Meeting. Austin, TX. March, 2015.

Ossama M. Maher, Anthony M. Christensen, Diana Bell, Nidale Tarek. Histone Deacetylase Inhibitor for NUT Midline Carcinoma. Pediatr Blood Cancer. 2015 Apr;62(4):715-7. doi: 10.1002/pbc.25350.

Christensen AM, Pauley JL, Molinelli AR, Panetta JC, Ward DA, Stewart CF, Hoffman JM, Howard SC, Pui CH, Pappo AS, Relling MV, Crews KR. Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer. 2012;118(17):4321-4330.

Ceja ME, Christensen AM, Yang SP. Dosing Considerations in Pediatric Oncology. US Pharm. 2013;(38)(Oncology suppl):8-11.

Chow J, Chicella M, Christensen A, Woodruff E, Moneymaker C, Harrington J, Dice J. Initiation of a pharmacist-managed RSV prevention clinic. Pediatric Pharmacy Advocacy Group Fall Meeting. St. Charles, MO. October, 2010.

Christensen AM, Woodruff ED, Chicella MF, Tiffany KF. An evaluation of caffeine for apnea of prematurity: once verses twice daily dosing. Pediatric Pharmacy Advocacy Group Spring Meeting. Salt Lake City, UT. April, 2010.

Virginia F. Schneider, Sung Kim, Anthony Christensen, et al. Implementation of Parameter Transfusion Orders for Stem Cell Transplant Recipients Results in Increased Nursing Autonomy, Decreased Transfusion Delays, and Improved Patient Care. Biology of Blood and Marrow Transplantation. Volume 20, Issue 2. Supplement. February 2014. Page S285. ISSN 1083-8791.

Last update: November 2018